Skip to main content
Home
Healthy-ojas

Main navigation

  • Diabetes
  • Cholesterol
  • Hypertension
  • Hypotension
  • Eye
  • Sleep
  • Natural
  • Calculators
User account menu
  • Log in

Breadcrumb

  1. Home

T2D Medicine SGLT2 inhibitors

Facebook Twitter Linkedin Pinterest
By Thiruvelan, 27 July, 2013
T2D Medicine SGLT2 inhibitors

SGLT2 inhibitors are a class of diabetes medication prevents the body to reabsorb glucose, increasing glucose excretions in urine to lower blood-glucose level.

SGLT2 inhibitors

SGLT2 inhibitors are sodium-glucose co-transporter 2 (SGLT2) inhibitors; it blocks the reabsorption of glucose into the body by the kidney and increasing glucose excretions in the urine. It is not recommendable for type 1 diabetes or diabetic ketoacidosis.

SGLT2 inhibitors mechanism of action

SGLT2 is a protein in humans that facilitates glucose reabsorption in the kidney. SGLT2 is responsible for almost 90% of the glucose reabsorption in the kidney. Inhibiting this transporter leads to a decrease in blood glucose due to the increase in renal glucose excretion.

The mechanism of action of this new class of drugs is by increasing insulin sensitivity, and uptake of glucose in the muscle cells decreased gluconeogenesis and improved first phase insulin release from the beta cells.

Drugs in the SGLT2 inhibitors class

  • Generic name: Canagliflozin (Brand name: Invokana),
  • Generic name: Dapagliflozin (Brand name: Farxiga (in the US), Forxiga (in EU)),
  • Generic name: Ipragliflozin (Brand name: Suglat)

SGLT2 inhibitors dosage

  • Canagliflozin – start with a minimum dose of 100 mg once daily for eGFR 45 to < 60 mL/min/1.73 m2, maximum dose of up to 300 mg once daily is allowable for patients with eGFR ≥60 mL/min/1.73 m2.
  • Dapagliflozin - start with a minimum dose of 5 mg orally once a day; take in the morning with or without food. You may increase to 10 mg once a day in patients is tolerating 5 mg/day who have an eGFR ≥60 mL/min/1.73 m² and require additional glycemic control.
  • Ipragliflozin - The recommended dose is 50 mg once daily, in the morning. If the effects are insufficient, the dosage may increase to up to 100 mg once a day, while carefully monitoring disease progress.

SGLT2 can increase the risk of hypoglycemia combined with insulin or an insulin secretagogue.

What can you expect from SGLT2 inhibitors?

SGLT2 inhibitors as monotherapy can reduce HbA1c levels. You can use SGLT2 inhibitors as a monotherapy or in combination with most other oral diabetes drugs and insulin.

Possible side effects of SGLT2 inhibitors

SGLT2 inhibitors can

increase LDL cholesterol,

urinary tract infections,

genital mycotic infections,

associated with increased urination and

episodes of hypotension and hypoglycemia).

The same report did show that the drug decreased weight by a 1.9 to 3% as well as reduced systolic and diastolic blood pressures and raised HDL cholesterol. Some common side effects are rapid weight loss, tiredness, and dehydration.

Who should avoid using SGLT2 inhibitors?

Avoid SGLT2 inhibitors, if you are

  • Type 1 diabetes
  • People with low kidney function
  • People taking strong diuretic medication
Facebook Twitter Linkedin Pinterest

Diabetes

  • Diabetes
  • Diabetes Causes
  • Newly Diagnosed D
  • Normal BG Level
  • A1C
  • Diabetes Type
  • Prediabetes
  • Type 2 diabetes
    • T2D Symptoms
    • T2D Risk Factors
    • T2D Screening
    • Diabetes Test
    • T2D SMBG
    • T2D Treatment
      • T2D Lifestyle
      • T2D Medications
        • Choose T2D Medicine
        • T2D Sulfonylurea
        • T2D Meglitinide
        • Biguanide (Metformin)
        • Thiazolidinedione
        • Alpha Glucosidase Inhibitors
        • DPP-4 Inhibitor
        • SGLT2 inhibitors
        • Combination Medicine
        • Incretin Byetta
      • Tight T2D Control
      • T2D Insulin Therapy
      • Prevent T2D
    • Diabetes Remission
  • Gestational Diabetes
  • Type 1 diabetes
  • Pregnancy with Diabetes
  • Hyperglycemia
  • Hypoglycemia
  • Ketoacidosis
  • Diabetes Products
  • Diabetes Supplements
  • Natural Treatments
  • Dawn Phenomenon
  • Somogyi Effect
  • Diabetic Coma
  • Diabetes Complications
RSS feed

Use of this Web site constitutes acceptance of our Privacy Policy
Health information is written & reviewed by Healthy-ojas team. The health content on this site is intended as a sharing of knowledge & information, and not to replace a relationship with a qualified health care professional. Always seek the advice of a Health Care Profession regarding any question you have about your health conditions, diagnosis, and treatments.

For eary navigation of the entire site, we request you to please visit Healthy-ojas Sitemap. 

About Us | Contact Us | Privacy Policy | Disclaimer | Advertisement Policy | Terms of Use